Jonathan D. Root - 16 Jun 2026 Form 4 Insider Report for Omada Health, Inc. (OMDA)

Reporting relationship: Director
Issuer ticker: OMDA
Reported as of: 16 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Jun 2026, 16:23:05 UTC
Prior SEC filing: 17 Jul 2026
Next SEC filing: 07 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Nathan Salha, as Attorney-in-Fact for Jonathan D. Root

Key filing fact

Jonathan D. Root filed Form 4 for Omada Health, Inc. (OMDA) on 18 Jun 2026.

Key facts

This page summarizes Jonathan D. Root's Form 4 filing for Omada Health, Inc. (OMDA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Jun 2026, 16:23.

Change

Previous filing in this sequence was filed on 17 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001225480 Primary reporting owner

ROOT JONATHAN D

Relationship: Director
Address: C/O OMADA HEALTH, INC., 611 GATEWAY BLVD., SUITE 120, SOUTH SAN FRANCISCO
Signature: /s/ Nathan Salha, as Attorney-in-Fact for Jonathan D. Root
Signature date: 18 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OMDA transaction

Common Stock

Award

Transaction value
Shares: +10,882
Change %: +6%
Price: $0.000000^*
Shares after: 191,057
Date: 16 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will fully vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, subject to continued service through such vesting date.